Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click
here.
Loading metrics
Open Access
Correction
Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
Keisuke Izumi,
Yuko Kaneko,
Misato Hashizume,
Keiko Yoshimoto,
Tsutomu Takeuchi
Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
